Pacific Biosciences of California Inc
XBER:P09

Watchlist Manager
Pacific Biosciences of California Inc Logo
Pacific Biosciences of California Inc
XBER:P09
Watchlist
Price: 1.4508 EUR Market Closed
Market Cap: €3.9B

Wall St Price Targets

P09 Price Targets Summary
Pacific Biosciences of California Inc

Wall Street analysts forecast P09 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for P09 is 1.8814 EUR with a low forecast of 0.8151 EUR and a high forecast of 2.5419 EUR.

Lowest Forecast
Price Target
0.8151 EUR
44% Downside
Average Forecast
Price Target
1.8814 EUR
30% Upside
Highest Forecast
Price Target
2.5419 EUR
75% Upside
Pacific Biosciences of California Inc Competitors:
Price Targets
MNPR
Monopar Therapeutics Inc
81% Upside
AGCO
AGCO Corp
10% Upside

Revenue
Forecast

12% / Year
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
12% / Year
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 14 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 7 years is 22%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-62%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-62%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is P09's stock price target?
Price Target
1.8814 EUR

According to Wall Street analysts, the average 1-year price target for P09 is 1.8814 EUR with a low forecast of 0.8151 EUR and a high forecast of 2.5419 EUR.

What is the Revenue forecast for Pacific Biosciences of California Inc?
Projected CAGR
22%

Over the last 14 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 7 years is 22%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett